Redefining Relapse in Efficacy Measures for Multiple Sclerosis Treatments
By: Stephen Krieger, MD; Enrique Alvarez, MD, PhD In this poster, Enrique Alvarez, MD, PhD., (from university of Colorado at…
Categories
Latest Blog Posts
- How Much Vitamin B12 Is Too Much?
- PRESS RELEASE –
- 2024 Revisions to McDonald Diagnostic Criteria for Multiple Sclerosis: Peter Calabresi, MD
- Conquering Dizziness: Everything You Need to Know About Vestibular Symptoms, Vestibular Migraine and How to Manage
- Home Safe Home: Tips for Creating an Accessible Space
- Driving without using your feet! Disability driving with hand controls – video
- Driving with Multiple Sclerosis
- How Age Affects MS Symptoms and Progression
- How to Sleep Better When You Have Chronic Pain
- COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review
- MEDICARE updates for 2025
- An MS Educational Skit: “Learning About The MS Immune System”
- Gabapentinoids, yet another dirty secret
- Help Make an IMPACT on Future MS Treatments
- The MS Mental Wellness Chat series
- RSVP for MS SYMPOSIUM 2024 in South Florida
- The Midnight Bathroom Run From Hell – a patient’s story
- The Effect of Seasonal Changes on Multiple Sclerosis
- A Case Study in Neurotherapeutic Clinical Trial Design and Conduct
- Let’s Move From Categorizing MS by Clinical Phenotype to Underlying Disease Mechanisms